E. coli lipopolysaccharide attenuates adenosine A(1) receptor-mediated increase in plasma exudation from the hamster cheek pouch

Inflamm Res. 2011 Feb;60(2):195-201. doi: 10.1007/s00011-010-0254-9. Epub 2010 Oct 6.

Abstract

Objective and design: To determine whether exposure to E. coli lipopolysaccharide (LPS) modulates adenosine A(1) receptor-induced increase in plasma exudation from the intact hamster cheek pouch microcirculation.

Methods and results: Using intravital microscopy, we found that suffusion of R(-)-N(6)-(2-phenylisopropyl)-adenosine (R(-)-PIA) (1.0 and 10.0 nM), a selective adenosine A(1) receptor agonist, onto the intact cheek pouch elicited significant, concentration-dependent leaky site formation and increase in clearance of fluorescein thioisocyanate-dextran (mol mass, 70 kDa) from post-capillary venules (p < 0.05). These responses were significantly attenuated by pre-treatment of hamsters with LPS (p < 0.05). By contrast, LPS had no significant effects on CGS-21680-, a selective adenosine A(2A) receptor agonist, bradykinin- and substance P-induced increases in plasma exudation from the cheek pouch.

Conclusion: These data indicate that LPS attenuates adenosine A(1) receptor-induced increase in plasma exudation in vivo in a specific fashion. We suggest that this phenomenon represents an endogenous anti-inflammatory cue to avoid excessive inflammation during Gram-negative bacterial infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bradykinin / pharmacology
  • Cheek / blood supply*
  • Cricetinae
  • Escherichia coli / chemistry*
  • Lipopolysaccharides / pharmacology*
  • Mesocricetus / anatomy & histology
  • Mesocricetus / metabolism
  • Microcirculation / drug effects*
  • Plasma / metabolism*
  • Receptor, Adenosine A1 / metabolism*
  • Substance P / pharmacology

Substances

  • Lipopolysaccharides
  • Receptor, Adenosine A1
  • Substance P
  • Bradykinin